Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. Under the multiyear deal, Zephyr AI will license M2Gen’s RWD and will, in return, provide M2Gen will AI and machine learning technologies to enhance its products and services.

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. The same principles are increasingly being applied to clinical trials to improve diversity, mitigate bias, and reinforce inclusion in clinical trials.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

pharmaphorum

APRIL 1, 2021

They go into bioinformatics”. There is some pharmaceutical activity with older and well-to-do companies, but they’re more focused on licensing than development.”. They go into bioinformatics.”. There are a lot of scientists who want to better understand biology but don’t have the money to do it in wet settings.

Bioinformatics 123

Bioinformatics Drugs Development Scientist 123

XTalks

SEPTEMBER 5, 2023

Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. In the majority of cases, the risk of VAED is brought to light during preclinical stages or early clinical trial phases.

Vaccine 96

Vaccine Vaccination Development Clinical Trials 96

XTalks

MAY 20, 2022

A Clinical Scientist will perform a wide range of duties depending on the focus of their research. Here is a summary of the kind of work you can expect to do: Design and implement clinical trials for human diseases and treatment. What Field Can You Work in as a Clinical Scientist? Liaise with stakeholders and scientists.

Scientist 105

Scientist Life Science Clinical Research Doctor 105

The Pharma Data

JULY 27, 2021

is a clinical stage biotechnology company developing a new class of biologics, Human Heavy-Chain Antibodies (UniAb®), for the treatments of cancer, autoimmunity, and infectious diseases. Even when clinical trials are successful, regulatory authorities may question the sufficiency for approval of the trial endpoints we have selected.

Production 52

Production Antibody Sales Development 52

The Pharma Data

OCTOBER 27, 2020

The growth in Orenitram revenues resulted primarily from an increase in quantities sold, as the number of patients being treated with Orenitram grew following the update to Orenitram’s labeling to reflect the FREEDOM-EV clinical trial results, partially offset by the impact of the Excess Order. 2020. .

Production 40

Production Sales Licensing Licensing 40